Recall Z-2215-2011 ยท MSW System, Test, Thyroglobulin
Beckman Coulter Inc.
Access Immunoassay Systems Thyroglobulin, Part Number: 33860 This device is intended to aid in monitoring for the presence of local and metastatic thyroid tissue in patients who have had thyroid gland ablation (using thyroid surgery with or without radioactivity) and who lack serum thyroglobulin antibodies.
| Date | May 19, 2011 (initiated Oct 18, 2010) |
| Status | Terminated |
| Reason | The recall was initiated because In addition to Access Tg Sample Diluent, an additional diluent, Access Wash Buffer II, was added to Thyroglobulin instructions for use (IFU) for evaluation of samples having Tg levels above the reportable range of the assay. When customers interchange between diluents there is an unacceptable shift in results. A median difference of 16% (ranging from 14% to 23%) b |
| Root cause | Other |
| Action | The firm, Beckman Coulter, sent an "URGENT: PRODUCT CORRECTIVE ACTION (PCA)" letter dated October 18, 2010, with attached PCA Response Form (via US Postal Service for US Customers) to all customers who purchased the Access Immunoassay Systems Thyroglobulin. The letter describes the product, problem and actions to be taken. The customers were instructed to: 1. Do not dilute elevated thyroglobulin samples with Wash Buffer II. 2. Do not run thyroglobulin patient samples using the onboard dilution feature on the UniCel DxI instrument. 3. Dilute elevated thyroglobulin samples only with Access |
| Quantity | 6,414 units |
| Distribution | Worldwide distribution: USA (nationwide) and country of: Canada. |
| FDA record | Open on fda.gov |